Anticoagulants and transaminase elevation

被引：33

作者：

Arora, N ^{[1
]}

Goldhaber, SZ ^{[1
]}

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc, Boston, MA 02115 USA

来源：

关键词：

D O I：

10.1161/CIRCULATIONAHA.105.603100

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：E698 / E702

页数：5

共 49 条

[1] Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions
Aithal, GP
Rawlins, MD
Day, CP
[J]. JOURNAL OF HEPATOLOGY, 2000, 33 (06) : 949 - 952
[2] Heparin-induced hepatotoxicity
AL-Mekhaizeem, KA
Sherker, AH
[J]. CANADIAN JOURNAL OF GASTROENTEROLOGY, 2001, 15 (08): : 527 - 530
[3] Albers GW, 2004, AM J MANAG CARE, V10, pS462
[4] Albers GW, 2005, JAMA-J AM MED ASSOC, V293, P690
[5] Albers GW, 2003, LANCET, V362, P1691
[6] Bamanikar A, 2002, J Assoc Physicians India, V50, P1456
[7] Bux-Gewehr I, 2000, THROMB HAEMOSTASIS, V83, P799
[8] *CARD REN DRUGS AD, 2004, FDA ADV COMM BRIEF D
[9] Elevation of hepatic transaminases after enoxaparin use: Case report and review of unfractionated and low-molecular-weight heparin-induced hepatotoxicity
Carlson, MK
Gleason, PP
Sen, S
[J]. PHARMACOTHERAPY, 2001, 21 (01): : 108 - 113
[10] CHAUDHRY S, 1995, AM J GASTROENTEROL, V90, P853